|Articles|August 1, 2010
- BioPharm International-08-01-2010
- Volume 23
- Issue 8
BioPharm International, August 2010 Issue (PDF)
Facilitate Cell Culture Process Development
Advertisement
Articles in this issue
over 15 years ago
Downstream Disposables: The Missing Link in the Disposables Chainover 15 years ago
Tug of Warover 15 years ago
Spanning the Globeover 15 years ago
Myriad Decision Places Biotech at a Crossroadsover 15 years ago
Manufacturing Compliance in the Spotlightover 15 years ago
USP <63> Mycoplasma Tests: A New Regulation for Mycoplasma TestingNewsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.
Advertisement
Advertisement
Advertisement
Trending on BioPharm International
1
FDA October 2025 Draft Guidance Sparks Industry Biosimilars Buzz
2
Adenovirus Vectors, Cyclodextrins and the Patient Experience: A Deep Dive
3
How Biopharma Navigates the 2026 Economic Shift
4
GSK Acquisition of RAPT Signals Shift Toward Long-Acting Anti-IgE Therapies
5
